A network for sharing data and resources in immuno-oncology
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
This study is bringing together cancer experts to find new ways to help patients by understanding why some cancers resist treatment and discovering better therapies, so that adults can either get rid of their cancer or stop it from happening in the first place.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-10800071 on NIH RePORTER |
What this research studies
This research focuses on enhancing the clinical application of immuno-oncology strategies by fostering collaboration among experts to understand cancer resistance mechanisms, identify new immune targets, and evaluate combination therapies. It aims to create a centralized hub for data management and analysis, which will streamline the research process and improve access to vital resources. By leveraging a multidisciplinary team, the project seeks to support innovative therapies that can either eliminate existing cancers in adults or prevent them from developing. Patients may benefit from the insights gained through this collaborative effort, which aims to advance treatment options in cancer care.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with various types of cancers who may benefit from innovative immunotherapy approaches.
Not a fit: Patients with non-malignant conditions or those who are not diagnosed with cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapy treatments for cancer patients.
How similar studies have performed: Previous research in immuno-oncology has shown promising results, indicating that collaborative approaches can lead to significant advancements in cancer treatment.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Hutson, Alan David — Roswell Park Cancer Institute Corp
- Study coordinator: Hutson, Alan David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.